(NASDAQ:BLBX), DALLAS, May 19, 2025 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), announces that its merger target REalloys Inc. (“REA” or “REalloys”), has signed a joint Memorandum of Understanding (“MOU”) with the Saskatchewan Research Council (“SRC”) to begin working together to advance REA's initiative of commercial production of high-performance rare earth […]

(NASDAQ:LFWD), MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has been appointed as the Company's new President and Chief Executive Officer,

(NasdaqGM:PRME), — First ever clinical data supporting safety and efficacy of Prime Editing in humans — — Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR positivity by Day 15 and 66% by Day 30, well above levels believed to be potentially curative — —

HANOI, Vietnam, May 19, 2025 (GLOBE NEWSWIRE) — Hyra Holdings, a global technology investment group, today announced the formal approval of the Hyra Combinator Fund, a $500 million venture initiative aimed at accelerating innovation in AI, fintech, and post-quantum security. The decision was made at the company's 2025 Annual General Meeting (AGM), where shareholders also

— Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder. Regulatory approval for the Phase II trial in PNH subjects was granted based on the safety profile of healthy subjects in the Phase I trial. Interim results from

(OTCQB:DUKR),(OTC US:DUKR), FT. LAUDERDALE, FL, May 19, 2025 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB:DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions, today announced the appointment of Mr. Yuval Hogeg as the International Business Development Director of the Company. Mr. Hogeg brings over two decades of expertise

New Century Logistics (BVI) Limited and Silk Way Airlines have reached a strategic cooperation to jointly explore a new pattern of international air logistics GlobeNewswire May 19, 2025 Hong Kong, China, May 19, 2025 (GLOBE NEWSWIRE) — On May 16, 2025 —- Hong Kong leading logistics solutions provider New Century Logistics (BVI) Limited (hereinafter referred

Lifeward Names Mark Grant as New CEO Industry veteran brings 30 years of commercial leadership experience GlobeNewswire May 19, 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease GlobeNewswire May 19, 2025 — First ever clinical data supporting safety and efficacy of Prime Editing in humans — — Initial data from first patient dosed in Phase 1/2 trial

Hyra Holdings Approves $500M Venture Fund and IPO Roadmap to 2030 at 2025 Annual Meeting GlobeNewswire May 19, 2025 HANOI, Vietnam, May 19, 2025 (GLOBE NEWSWIRE) — Hyra Holdings, a global technology investment group, today announced the formal approval of the Hyra Combinator Fund, a $500 million venture initiative aimed at accelerating innovation in AI,